The OS T-reg cells expressed the canonical gene signature including the FOXP3 and IL2RA (Fig. 7d, e), and they also showed relatively high immune-inhibitory molecules including the CTLA4 and TIGIT, which may contribute to T-reg cell-mediated suppression of anti‐tumor immune responses in OS lesions. The gene discussed is IL2RA; the disease is neoplasm.